Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae is a research paper published in JAC-Antimicrobial Resistance (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIH
Grant: R21AI151363
NIAID NIH HHS
Grant: R01 AI127472
NIAID NIH HHS
Grant: R03 AI144636
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords